Li Zonglin, Cao Hongchun, Yao Ming, Lei Xiao
Department of Traditional Chinese Medicine, Affiliated Hospital of North Sichuan Medical College Nanchong, Sichuan Province, China.
First Department of Internal Medicine, Nanchong Hospital of Traditional Chinese Medicine Nanchong, Sichuan Province, China.
Am J Transl Res. 2021 Apr 15;13(4):3409-3417. eCollection 2021.
To explore the effect of acupuncture combined with Shenqi Yigan Decoction on liver function and T cell subsets in patients with Hepatitis B virus-induced liver fibrosis.
All of the 90 patients with HBV-induced liver fibrosis were divided into two groups with the control group (n=45) treated with the conventional treatment, and the observation group (n=45) treated with acupuncture and Shenqi Yigan decoction based on the observation group. The seroconversion rate of hepatitis Be antigen (HBeAg), the liver function, the serum indexes of liver fibrosis of hyaluronic acid (HA), laminin (LN), type III procollagen (PC III), type IV collagen (IV-C), the T cell subsets and the inflammatory factors were compared between the two groups.
After 2 and 4 months of treatment, the HBeAg seroconversion rate of patients in the observation group was higher than that of the control group, but the difference was not significant (P>0.05). And the HBeAg seroconversion rate of patients in the observation group was significantly higher than that of the control group after 6 months treatment (P<0.05). After treatment, the serum levels of the liver function index of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (Tbil), the liver fibrosis index of HA, LN, PC III, and the inflammatory factor of type IV collagen (IV-C), C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α) in the two groups were lower than those before treatment, in addition, the levels of there index were lower in the observation group (all P<0.05). After treatment, the proportion of CD3, CD4 T lymphocyte subsets and CD4/CD8 in peripheral blood of the two groups were increased, and the proportion of CD8 was decreased. The change range of the observation group was larger than that of the observation group (all P<0.01). The proportion of patients with liver fibrosis grade F1 in the observation group after treatment was significantly higher than that before treatment, and the proportion of patients with liver fibrosis grade F2 to F3 was significantly lower than that before treatment. There was a significant difference in liver fibrosis grade between the two groups after treatment (P<0.05).
The combined treatment of acupuncture and Shenqi Yigan decoction can significantly improve the liver function of patients with HBV-induced liver fibrosis, delay the progress of liver fibrosis, improve the cellular immune function and reduce the inflammatory reaction.
探讨针刺联合参芪益肝汤对乙型肝炎病毒所致肝纤维化患者肝功能及T细胞亚群的影响。
将90例乙型肝炎病毒所致肝纤维化患者分为两组,对照组(n = 45)采用常规治疗,观察组(n = 45)在对照组基础上采用针刺联合参芪益肝汤治疗。比较两组患者乙肝e抗原(HBeAg)血清学转换率、肝功能、透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(Ⅳ - C)等肝纤维化血清指标、T细胞亚群及炎症因子水平。
治疗2个月和4个月后,观察组患者HBeAg血清学转换率高于对照组,但差异无统计学意义(P > 0.05);治疗6个月后,观察组患者HBeAg血清学转换率显著高于对照组(P < 0.05)。治疗后,两组患者血清肝功能指标天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、总胆红素(Tbil),肝纤维化指标HA、LN、PCⅢ及炎症因子Ⅳ型胶原(Ⅳ - C)、C反应蛋白(CRP)、肿瘤坏死因子 -α(TNF -α)水平均低于治疗前,且观察组上述指标水平更低(均P < 0.05)。治疗后,两组外周血CD3、CD4 T淋巴细胞亚群比例及CD4/CD8升高,CD8比例降低,观察组变化幅度大于对照组(均P < 0.01)。治疗后观察组肝纤维化F1级患者比例显著高于治疗前,肝纤维化F2至F3级患者比例显著低于治疗前,两组治疗后肝纤维化分级差异有统计学意义(P < 0.05)。
针刺联合参芪益肝汤治疗可显著改善乙型肝炎病毒所致肝纤维化患者肝功能,延缓肝纤维化进程,提高细胞免疫功能,减轻炎症反应。